International Clinical Trial: A single-center, single-arm clinical trial to evaluate the efficacy of Liaoshen roe nanoactive peptide functional drink in women with diminished ovarian function

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128717) titled 'A single-center, single-arm clinical trial to evaluate the efficacy of Liaoshen roe nanoactive peptide functional drink in women with diminished ovarian function' on July 24.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Shengjing Hospital Affiliated to China Medical University.

Condition: Diminished ovarian function

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-13

Target Sample Size: experimental group:32;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=311778

Disclaimer: Curated by HT Syndi...